Rare Disease Summit is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Janet Maynard, MD, MHS
Director, Office of Orphan Products Development at Food and Drug Administration

Agenda Sessions

  • Regulatory and Policy Update Address Keynote